Biotechnological Enzymatic Catalyse SA
0.9 FTEBiotechnological Enzymatic Catalyse reported total assets of €1.22m at the end of the 2025 financial year (annual accounts filed with the NBB on 04 Jun 2026), with 0.9 full-time equivalent.
The score of Biotechnological Enzymatic Catalyse shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -45 % Total assets -44 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biotechnological Enzymatic Catalyse's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 04 Jun 2026
- Year ended 31 Dec 2024filed on 28 May 2025
- Year ended 31 Dec 2023filed on 31 May 2024
- Year ended 31 Dec 2022filed on 06 Jun 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
Biotechnological Enzymatic Catalyse's financial analysis
- Solvency82.4%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biotechnological Enzymatic Catalyse
6 active director(s) in the register.
Biotechnological Enzymatic Catalyse's shareholders and holdings →Biotechnological Enzymatic Catalyse's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0446.755.472
- VAT number
- BE0446755472
- Peppol
- Registered · 0208:0446755472 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 26 Feb 1992
- Registered office
- 9820 Merelbeke-Melle
- Size
- Micro · 0.9 FTE
- Latest accounts
- 2025 · filed on 04 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Biotechnological Enzymatic Catalyse (SA) has been based in Merelbeke-Melle since 1992, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 421,920 € and equity of €1.01m; its revenue is not published. With 0.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 82.4%, above the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Biotechnological Enzymatic Catalyse
Companies in the same business, of comparable size and area, outside its group.
- Rembrandt Medical Wholesale of pharmaceutical and medical goods Nazareth · balance sheet €1.08m
- Cirba Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 67,062 €
- Nutrifarma Wholesale of other food Heist-op-den-Berg · balance sheet €1.80m
- Laboratoires Forte Pharma Benelux Wholesale of other food Brussels · balance sheet €1.85m
- Unit Communication - CBF Médical Wholesale of pharmaceutical and medical goods Gembloux · balance sheet 764,164 €
- Hyloris Wholesale of pharmaceutical and medical goods Liège · balance sheet €1.58m
- Stylepharma Wholesale of pharmaceutical and medical goods Waterloo · balance sheet 503,082 €
- Adhoc Medical Wholesale of pharmaceutical and medical goods Verviers · balance sheet €1.69m
Frequently asked questions about Biotechnological Enzymatic Catalyse
What is the revenue of Biotechnological Enzymatic Catalyse?
Biotechnological Enzymatic Catalyse files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biotechnological Enzymatic Catalyse?
In Belgium, the VAT number is the company number prefixed with BE: BE0446755472 for Biotechnological Enzymatic Catalyse, if the company is VAT-registered. Its company number (CBE) is 0446.755.472.
Where is the registered office of Biotechnological Enzymatic Catalyse?
According to the CBE register, the registered office of Biotechnological Enzymatic Catalyse is in 9820 Merelbeke-Melle.
What is the equity of Biotechnological Enzymatic Catalyse?
At the close of the 2025 financial year, the equity of Biotechnological Enzymatic Catalyse amounts to 1,006,816 €, a solvency of 82.4% of total assets.
How many people work at Biotechnological Enzymatic Catalyse?
0.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Biotechnological Enzymatic Catalyse?
The register lists 6 active mandates at Biotechnological Enzymatic Catalyse. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biotechnological Enzymatic Catalyse
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →